“Since 2006 — five years after the start of major combat operations in Afghanistan and three years after the U.S.-led invasion of Iraq — a total of 16,652 active duty personnel and mobilized reservists have died while serving in the U.S. armed forces,” the Congressional Research Service said, based on data obtained from the Department of Defense. See Recent Trends in Active-Duty Military Deaths, CRS In Focus, updated May 20, 2019.
Other new and updated reports from the Congressional Research Service include the following.
Military Personnel and Extremism: Law, Policy, and Considerations for Congress, CRS Insight, updated May 16, 2019
United States Foreign Intelligence Relationships: Background, Policy and Legal Authorities, Risks, Benefits, May 15, 2019
Global Human Rights: The Department of State’s Country Reports on Human Rights Practices, CRS In Focus, updated May 20, 2019
Combating Corruption in Latin America: Congressional Considerations, May 21, 2019
Cuba: Trump Administration Expands Sanctions, CRS Insight, May 17, 2019
The European Parliament and U.S. Interests, CRS In Focus, May 16, 2019
Long Live Cash: The Potential Decline of Cash Usage and Related Implications, May 10, 2019
Electronic Messaging Recordkeeping Requirements, CRS In Focus, May 21, 2019
Confirmation that the construction of the security perimeter and associated security infrastructure at RAF Lakenheath are still ongoing once again raises questions about whether U.S. nuclear weapons have already been deployed to the base.
Alaskans are sensibly pulling back from the vogue for bans and returning to a western tradition that has worked for more than half a century – one that welcomes innovation but also oversees it closely.
The strength of our nation’s data policy isn’t just in the rules we write, but in how effectively we translate those rules into a system that prioritizes the public good. Join us in this movement to design and build more resilient national data policies.
The human cost is measured in deaths. The financial cost is measured in the $52 billion taxpayers pay annually end stage renal disease – double NASA’s budget.